home · filing · 0001077183-21-000190
8-K/A filed July 15, 2021, 7:59 PM ET
ticker NEO
CIK 0001077183
leadership
confidence high
sentiment neutral
materiality 0.50
NeoGenomics discloses compensation details for Clive Morris as President of Inivata subsidiary
NEOGENOMICS INC
Base salary of £405,000 per year; eligible for annual performance bonus targeted at 50% of base salary.
Retention cash bonus of £607,500, 50% payable June 30, 2022 if employed, remainder per agreement.
Equity award valued at $1.4M: 10,708 RSUs (4-year vest) and option for 53,857 shares (7-year term, 4-year vest).
Cash payment of $100,000 within 30 days of Inivata acquisition close.
Subject to non-competition and non-solicitation covenants; participates in Inivata pension scheme.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Clive Morris
President of Inivata
Effective 2021-06-18
Filed July 15, 2021, 7:59 PM ET
in connection with Mr. Morris’s appointment as President of Inivata.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Clive Morris was appointed as President of Inivata at NEOGENOMICS INC.
Action appointed
Role President of Inivata
Exact text from the filing
in connection with Mr. Morris’s appointment as President of Inivata.
View on SEC.gov
Source: SEC EDGAR
accession 0001077183-21-000190
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.